MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.
In conclusion, miR-877 may play an antitumor role in cervical cancer by directly targeting MACC1, which suggests that this miRNA may be a promising therapeutic target for the treatment of patients with such an aggressive gynecological cancer.
PMID: 31602243 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Colon Cancer | Colorectal Cancer | General Medicine | Genetics | Hepatocellular Carcinoma | Kidney Cancer | Liver Cancer | Men | OBGYN | Renal Cell Carcinoma | Study